Aspire Biopharma Holdings, Inc. (ASBP)
NASDAQ: ASBP · Real-Time Price · USD
1.235
+0.075 (6.47%)
Mar 9, 2026, 3:43 PM EDT - Market open
Aspire Biopharma Holdings Market Cap
Aspire Biopharma Holdings has a market cap or net worth of $6.20 million as of March 9, 2026. Its market cap has decreased by -99.99% in one year.
Market Cap
6.20M
Enterprise Value
12.60M
1-Year Change
-99.99%
Ranking
Category
Stock Price
$1.24
Market Cap Chart
Since April 11, 2022, Aspire Biopharma Holdings's market cap has decreased from $349.65M to $6.20M, a decrease of -98.23%. That is a compound annual growth rate of -64.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 5.83M | -58.89% |
| Dec 31, 2025 | 14.18M | -84.12% |
| Dec 18, 2024 | 89.30M | -8.80% |
| Dec 29, 2023 | 97.91M | -73.55% |
| Dec 30, 2022 | 370.16M | 5.86% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aptorum Group | 6.43M |
| XTL Biopharmaceuticals | 6.43M |
| Mustang Bio | 6.42M |
| Can-Fite BioPharma | 6.38M |
| Processa Pharmaceuticals | 6.30M |
| Moolec Science | 6.22M |
| Aprea Therapeutics | 6.09M |
| Purple Biotech | 6.02M |